Health News Archive - May 11, 2009
BOTHELL, WA and VANCOUVER, May 11 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc.
MOUNTAIN VIEW, Calif., May 11 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that its corporate presentation will be webcast live during the Eighth Annual JMP Securities Research Conference on Monday, May 18, 2009 at 3:30 p.m. Pacific Time.
LYNBROOK, N.Y., May 11 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the first quarter ended March 31, 2009.
LONDON, May 11 /PRNewswire/ -- Empty offices and deserted restaurants are a real possibility if the Swine Flu virus successfully mutates, warns the Economist Intelligence Unit. The public has been suffering from "gloom fatigue" with constant bad news over the recession.
2009 First Quarter Highlights -- Received $22.5 million from the sale of a mortgage investment in February 2009. -- Paid down entire $37.8 million of debt outstanding under warehouse line in March 2009 and retired facility. -- Current cash and cash equivalents of approximately $46 million. NEW YORK, May 11 /PRNewswire-FirstCall/ -- Care Investment Trust Inc.
BALTIMORE, Md., May 11 /PRNewswire/ -- Hope Solution, a 501-C3 nonprofit organization, is announcing its first national 6 hour "Change that Matters" webcast telethon at Sojourner-Douglass College, located in Baltimore Maryland.
RONKONKOMA, N.Y., May 11 /PRNewswire-FirstCall/ -- NBTY, Inc.
Growth of DORYX, LOESTRIN 24 FE and ESTRACE CREAM drives solid earnings growth. ARDEE, Ireland, May 11 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2009.
ARDEE, Ireland, May 11 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced that its Board of Directors has unanimously approved the redomestication of the Company from Bermuda to Ireland.
- Easy-to-swallow formulation provides important new alternative for patients RESEARCH TRIANGLE PARK, N.C., May 11 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S.
- A person in a secondary role, specifically the second most important character (after the protagonist).